QQQ   431.77 (+0.16%)
AAPL   169.38 (-1.92%)
MSFT   416.03 (+0.58%)
META   502.05 (+0.36%)
GOOGL   154.65 (-0.14%)
AMZN   183.75 (+0.07%)
TSLA   156.93 (-2.82%)
NVDA   872.21 (+1.42%)
AMD   163.28 (+1.85%)
NIO   3.81 (-2.06%)
BABA   69.89 (-1.03%)
T   16.05 (-1.17%)
F   12.16 (-0.57%)
MU   121.30 (-0.06%)
GE   155.76 (+1.34%)
CGC   6.88 (-1.43%)
DIS   114.11 (+1.03%)
AMC   2.72 (+10.12%)
PFE   25.84 (-0.27%)
PYPL   63.96 (+0.71%)
XOM   118.78 (-0.75%)
QQQ   431.77 (+0.16%)
AAPL   169.38 (-1.92%)
MSFT   416.03 (+0.58%)
META   502.05 (+0.36%)
GOOGL   154.65 (-0.14%)
AMZN   183.75 (+0.07%)
TSLA   156.93 (-2.82%)
NVDA   872.21 (+1.42%)
AMD   163.28 (+1.85%)
NIO   3.81 (-2.06%)
BABA   69.89 (-1.03%)
T   16.05 (-1.17%)
F   12.16 (-0.57%)
MU   121.30 (-0.06%)
GE   155.76 (+1.34%)
CGC   6.88 (-1.43%)
DIS   114.11 (+1.03%)
AMC   2.72 (+10.12%)
PFE   25.84 (-0.27%)
PYPL   63.96 (+0.71%)
XOM   118.78 (-0.75%)
QQQ   431.77 (+0.16%)
AAPL   169.38 (-1.92%)
MSFT   416.03 (+0.58%)
META   502.05 (+0.36%)
GOOGL   154.65 (-0.14%)
AMZN   183.75 (+0.07%)
TSLA   156.93 (-2.82%)
NVDA   872.21 (+1.42%)
AMD   163.28 (+1.85%)
NIO   3.81 (-2.06%)
BABA   69.89 (-1.03%)
T   16.05 (-1.17%)
F   12.16 (-0.57%)
MU   121.30 (-0.06%)
GE   155.76 (+1.34%)
CGC   6.88 (-1.43%)
DIS   114.11 (+1.03%)
AMC   2.72 (+10.12%)
PFE   25.84 (-0.27%)
PYPL   63.96 (+0.71%)
XOM   118.78 (-0.75%)
QQQ   431.77 (+0.16%)
AAPL   169.38 (-1.92%)
MSFT   416.03 (+0.58%)
META   502.05 (+0.36%)
GOOGL   154.65 (-0.14%)
AMZN   183.75 (+0.07%)
TSLA   156.93 (-2.82%)
NVDA   872.21 (+1.42%)
AMD   163.28 (+1.85%)
NIO   3.81 (-2.06%)
BABA   69.89 (-1.03%)
T   16.05 (-1.17%)
F   12.16 (-0.57%)
MU   121.30 (-0.06%)
GE   155.76 (+1.34%)
CGC   6.88 (-1.43%)
DIS   114.11 (+1.03%)
AMC   2.72 (+10.12%)
PFE   25.84 (-0.27%)
PYPL   63.96 (+0.71%)
XOM   118.78 (-0.75%)
OTCMKTS:BTCY

Biotricity (BTCY) Stock Price, News & Analysis

$1.34
+0.19 (+16.52%)
(As of 04/15/2024 ET)
Today's Range
$1.16
$1.51
50-Day Range
$0.74
$1.63
52-Week Range
$0.70
$5.10
Volume
564,681 shs
Average Volume
76,862 shs
Market Capitalization
$12.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BTCY stock logo

About Biotricity Stock (OTCMKTS:BTCY)

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

BTCY Stock Price History

BTCY Stock News Headlines

Biotricity (OTCMKTS:BTCY) Trading Up 0.9%
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Biotricity Inc BTCY
Biotricity's Earnings Outlook
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Biotricity reports Q2 results
Earnings Outlook For Biotricity
See More Headlines
Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/20/2024
Today
4/16/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
OTCMKTS:BTCY
Fax
N/A
Employees
55
Year Founded
N/A

Profitability

Net Income
$-18,660,000.00
Net Margins
-163.11%
Pretax Margin
-163.11%

Debt

Sales & Book Value

Annual Sales
$11.63 million
Book Value
($2.67) per share

Miscellaneous

Free Float
6,963,000
Market Cap
$12.62 million
Optionable
Not Optionable
Beta
1.51
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Dr. Waqaas Al-Siddiq Ph.D. (Age 39)
    Founder, President, CEO & Chairman
    Comp: $732k
  • Mr. S. John Ayanoglou (Age 57)
    Chief Financial Officer
    Comp: $305.75k
  • Mr. Andy Wong
    Vice President of Operations
  • Dr. George N. Nikopoulos
    Director of Business Development
  • Mr. Matt Zabel
    Vice President of Sales & Strategy
  • Mr. Amir Ali
    Chief Development Officer

BTCY Stock Analysis - Frequently Asked Questions

How have BTCY shares performed in 2024?

Biotricity's stock was trading at $1.15 on January 1st, 2024. Since then, BTCY stock has increased by 16.5% and is now trading at $1.34.
View the best growth stocks for 2024 here
.

How were Biotricity's earnings last quarter?

Biotricity, Inc. (OTCMKTS:BTCY) issued its quarterly earnings results on Tuesday, February, 20th. The company reported ($0.34) EPS for the quarter, beating analysts' consensus estimates of ($0.41) by $0.07. The business earned $2.97 million during the quarter, compared to analyst estimates of $3 million.

When did Biotricity's stock split?

Biotricity shares reverse split on Monday, July 3rd 2023. The 1-6 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

What other stocks do shareholders of Biotricity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Biotricity investors own include Axsome Therapeutics (AXSM), Bank of America (BAC), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Broadcom (AVGO), Cannabix Technologies (BLOZF), BioLineRx (BLRX), CV Sciences (CVSI) and Charlotte's Web (CWBHF).

How do I buy shares of Biotricity?

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BTCY) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners